Patients' artwork to remember Covid challenges
Art therapist Andy Walker, from the Tees, Esk and Wear Valleys NHS Foundation Trust (TEWV), said the Tree of Life project featured 2,025 images documenting the pandemic and was a "snapshot of history".
It also includes selfies of the mental health trust's staff and patients during lockdown.
Mr Walker said the display was a "lasting reminder of the pandemic, honouring the struggles faced, the unity found, and the hope for the future".
The work is a composite image created by the juxtaposition of the individual pictures to form a tree of life - a symbol representing the life cycle.
Large posters featuring the artwork are being placed at sites across the mental health trust, which manages sites including Acklam Road Hospital in Middlesbrough and Auckland Park Hospital in Bishop Auckland.
The trust's lead occupational therapist Rachel Booth-Gardiner, is among those to feature in the project.
Her life was turned upside down when she got Covid in 2020 and had to spend a year in hospital, including five months in intensive care.
Due to muscle wastage and other complications, Mrs Booth-Gardiner had to relearn how to control her body.
It took a further six months of rehabilitation after she left hospital for her to be well enough to return to work full-time using a wheelchair.
Her husband Anthony, a photographer, documented her recovery journey to capture her resilience and he helped put the final artwork together.
Mrs Booth-Gardiner said: "It might bring back difficult memories, but I hope it shows the strength people have.
"It is testament to the solidarity and hope that carried us through challenging times."
Follow BBC North East on X, Facebook, Nextdoor and Instagram.
'Uplifting' Covid memorial proposed for park
Memorial plan for coronavirus deaths
TEWV
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
43 minutes ago
- Associated Press
Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors
( NewMediaWire ) - July 16, 2025 - DALLAS — The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change the future of health and improve cardiovascular and cerebrovascular health outcomes, which continue to be leading causes of death in the United States. Double board-certified in Ob-Gyn and obesity medicine, Dr. Jennifer Ashton is a nationally recognized women's health advocate known for communicating complex medical topics in an accessible way. As ABC News' Chief Medical Correspondent, she became a nationally trusted voice during major public health events, including the COVID-19 pandemic. A Columbia duPont and Emmy Award-winning journalist, a bestselling author and champion of preventive health and mental wellness, Dr. Ashton has volunteered with the American Heart Association for more than a decade, frequently speaking at local Go Red for Women(R) events. She has received numerous honors from the Association, including the 2024 Heart Saver Hero Award, the 2023 ' Woman Changing the World Award ' and the Go Red for Women Award in 2018. These accolades reflect her tireless advocacy for women's cardiovascular health and her leadership in advancing the Association's mission through education and action. 'As the obesity and maternal mortality epidemics are two of the most pressing issues affecting women in the U.S., and since both have cardiovascular associations, I hope that my experience and expertise in these fields can assist the American Heart Association's efforts,' Ashton said. 'And, as the daughter of a cardiologist, I am honored to be the first OB-GYN appointed to the Board in the history of the Association.' As a board-certified cardiothoracic surgeon, cardiovascular surgeon and transplant surgeon, Dr. Joseph Woo is a nationally recognized leader and educator in cardiac surgery innovation. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery, associate director of the Stanford Cardiovascular Institute and the Norman E. Shumway Professor of Cardiothoracic Surgery. He has pioneered advanced surgical research on multiple studies and clinical trials, including numerous National Institutes of Health (NIH) grant projects, as well as American Heart Association grants to study ways to treat heart failure through cellular repair. In 2021, he received the Association's Clinical Research Prize for his groundbreaking work in minimally invasive heart valve repair. Earlier in his career, he received the Vivien Thomas Young Investigator Award (1997) for postdoctoral research on molecular strategies to reduce myocardial ischemic injury. Dr. Woo holds patents for several heart-related medical devices and surgical techniques and has co-authored over 490 peer-reviewed papers. Beyond his research, he is deeply committed to mentorship, global collaboration and advancing medical education in cardiovascular health. 'As a physician-scientist, I have been a daily witness to the tragedy of cardiovascular disease on human life, and also to the triumph of improving health and saving lives through scientific discovery,' Woo said. 'The American Heart Association is a global leader in supporting vital research and establishing the best evidenced-based approaches to cardiovascular health and treatment grounded in basic science, engineering, translational and clinical investigation. I look forward to continuing to support the Association as we continue our bold endeavors toward a healthier world for all.' 'We are honored to welcome Dr. Jen Ashton and Dr. Joe Woo to our Board of Directors,' said Nancy Brown, CEO of the American Heart Association. 'Dr. Ashton's national media profile, influence and dedication to preventive health, alongside Dr. Woo's groundbreaking work in cardiovascular surgery and academic leadership, uniquely position them to help us change the future of health and drive forward our mission. Their perspectives will be instrumental as we continue our work to bring health and hope to everyone, everywhere.' These appointments reflect the American Heart Association's continued commitment to science-based solutions, community-centered approaches and bold leadership in the fight against heart disease and stroke. The American Heart Association's Board of Directors is the organization's top volunteer governing body, working closely with CEO Nancy Brown to provide strategic oversight and financial stewardship to advance the organization's mission of longer, healthier lives for all. Board members also serve as ambassadors, leveraging their individual professional expertise and networks of influence to further extend, accelerate and elevate the Association's visibility, impact and collaborations. Additional Resources ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Suzanne Grant: [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
The Hill
an hour ago
- The Hill
No link found between aluminum in vaccines and autism: Study
(NewsNation) — A new study out of Denmark challenges claims that aluminum in childhood vaccines poses health risks. Researchers analyzed the health records of more than 1.2 million children over a 24-year period. The study, published Monday in the Annals of Internal Medicine, found no evidence linking aluminum exposure from vaccines to any increase in chronic conditions such as asthma, autism, or autoimmune diseases. Aluminum salts are commonly used in vaccines as adjuvants to enhance immune response, according to the Children's Hospital of Philadelphia. COVID-19 cases surge in half of US, particularly South and West While critics have long raised concerns about the potential health hazards of aluminum, the study found no association between vaccine-related aluminum and any of the 50 chronic conditions examined, including 36 autoimmune disorders, nine conditions related to allergies or asthma and five neurodevelopmental disorders. Researchers used Denmark's nationwide registry to track vaccine history and medical outcomes for children born between 1997 and 2018, following them through the end of 2020. Researchers assessed aluminum exposure by age 2 and compared outcomes across varying exposure levels. The study didn't include unvaccinated children. Only 1.2 percent of children received no 'aluminum-adsorbed vaccines' before age 2. The rest received varying doses, with total aluminum exposure ranging from 0.125 mg to 1.00 mg per dose. The median exposure across the cohort was approximately 3 mg.
Politico
2 hours ago
- Politico
Trump's next health nominee in the hot seat
Presented by With help from Simon Levien Driving the Day CHRISTINE FACES QUESTIONING — President Donald Trump's choice for a top post at HHS, Dr. Brian Christine, goes before senators today for a confirmation hearing. Christine will face questioning from the Senate Health, Education, Labor and Pensions Committee as lawmakers consider his nomination to be assistant secretary for health — one of the highest-ranking jobs at HHS and a position often held by admirals in the Commissioned Corps of the U.S. Public Health Service. Why it matters: If he advances through the committee and is eventually confirmed by the full Senate, Christine, a men's sexual health doctor and GOP donor, would oversee thousands of uniformed public-health service members and be charged with carrying out Health Secretary Robert F. Kennedy Jr.'s public health agenda, Simon reports. One of the highest-ranking positions at the agency, the assistant secretary for health advises the HHS secretary and recommends policy related to public health matters like disease prevention, vaccine programs and health disparities. He would also help lead a new HHS office called the Administration for a Healthy America, which consolidates existing agency offices to focus on primary care, maternal and child health, mental health, environmental health, HIV/AIDS and workforce development. Background: Christine, a urologic surgeon at Urology Centers of Alabama, has previously criticized the acceptance of transgender health care and the federal government's response to the Covid-19 pandemic. He's expressed opposition to trans athletes competing in women's sports and has said on his podcast — called 'Common Sense,' and last airing two years ago — that children experiencing gender dysphoria should seek counseling or 'pastoral care,' not gender-affirming treatments. He's also come under scrutiny after The Wall Street Journal reported in March that his Alabama urology practice advertised its work treating transgender men with erectile dysfunction. Christine has denied treating trans patients. Since taking office, Trump has directed HHS to restrict access to gender-affirming care treatments for children and teens. The Alabama GOP has praised Christine's nomination, calling him 'a longtime Conservative grassroots activist and dedicated supporter of the Alabama Republican Party.' In 2024, Christine contributed more than $8,500 to Trump's campaign. Key context: Dr. Rachel Levine, a pediatrician and the highest-ranking openly trans person to serve at the federal level, held the job during the Biden administration. Levine, who used the post to advocate gender-affirming care, was frequently the target of anti-trans attacks from Trump and his allies. WELCOME TO WEDNESDAY PULSE. Today marks the third anniversary of the 988 Suicide & Crisis Lifeline, and awareness of the hotline is up dramatically from 2022, according to a new National Alliance on Mental Illness poll. Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @kelhoops and @sophie_gardnerj. HAWLEY'S ABOUT-FACE — Just weeks after voting for massive cuts to Medicaid in the GOP's 'big, beautiful bill,' Missouri Republican Sen. Josh Hawley introduced a bill Tuesday that would walk back those cuts. Hawley repeatedly voiced his opposition to deep Medicaid cuts throughout the megabill negotiation process, specifically provisions that would hit rural hospitals. But he ultimately voted 'yes' on the recently enacted legislation, which contains more than $1 trillion in health care cuts and a provision that would cap state provider taxes — a move that hospitals have said could deeply reduce their revenue and limit access to health care for millions of Medicaid enrollees. Hawley said he voted for the bill's passage after negotiating for the inclusion of a $50 billion rural hospital fund but said at the time that he would 'continue to do everything in my power to reverse future cuts to Medicaid.' His new legislation, the Protect Medicaid and Rural Hospitals Act, would repeal the megabill's moratorium on taxes that states impose on providers to generate more Medicaid funding, which helps boost payments to hospitals. Hawley's bill would repeal megabill provisions that reduce state-directed payments — which enable states to increase the rates that privately run Medicaid managed care plans reimburse providers. His legislation would also double the megabill's investment in the rural hospital fund to $100 billion and extend the fund from five to 10 years. 'President Trump has always said we have to protect Medicaid for working people. Now is the time to prevent any future cuts to Medicaid from going into effect,' Hawley said in a news release. Global Health PEPFAR U-TURN — Senate Republicans on Tuesday stripped cuts to global AIDs funding from the White House's $9.4 billion spending clawback request, POLITICO's Jordain Carney and Cassandra Dumay report. Republicans will remove a $400 million cut to the global AIDS program known as PEPFAR, reducing the amount of cuts in the package to $9 billion, said Sen. Eric Schmitt (R-Mo.), who's leading the rescissions effort in concert with the White House. Senate Majority Leader John Thune said he expects the removal to be the only change made to the rescissions package, adding that there was a 'lot of interest' among Senate Republicans to address the cut to the program created under then-President George W. Bush and credited with saving tens of millions of lives. News of the change came after White House Budget Director Russ Vought briefed senators during a closed-door lunch Tuesday. Schmitt said the White House is on board with the change. 'We're fine with adjustments,' Vought told reporters. 'This is still a great package, $9 billion, substantially the same package. The Senate has to work its will, and we've appreciated the work along the way to get to a place where they think they've got the votes.' Background: Several GOP senators, including Appropriations Chair Susan Collins of Maine, had raised concerns about the AIDS funding cuts. It's unclear whether the $400 million rollback will be enough to secure her vote, but it might placate enough Republicans to advance the package through the Senate. Other Republicans being watched closely are Alaska Sen. Lisa Murkowski, Kentucky Sen. Mitch McConnell and Kansas Sen. Jerry Moran. At the Agencies HOSPITAL PAY CUT — The Trump administration is proposing cutting $280 million in payments to certain hospital clinics for administering drugs to patients, POLITICO's Robert King reports. The Centers for Medicare and Medicaid Services said the cut would ensure that Medicare beneficiaries aren't charged more for the same service at a hospital than at an independent clinic. The proposed rule is likely to generate fierce pushback from the hospital industry, which has successfully fought similar congressional efforts. The rule also outlines 2026 Medicare payment rates for hospital outpatient services and ambulatory surgical centers and includes new changes to boost price transparency. 'These reforms expand options and enforce the transparency Americans deserve to ensure they receive high-quality care without hidden costs,' CMS Administrator Mehmet Oz said in a statement. Background: The first Trump administration adopted a policy in 2019 to lower payments for outpatient hospital clinics to align them with those of independent clinics. Now, CMS wants to expand that policy to include services for storing or administering pharmaceuticals to patients. The agency estimates the change will reduce Medicare spending by $280 million, with $210 million allocated to Medicare and $70 million to Medicare beneficiaries thanks to lower co-insurance rates, according to a fact sheet on the rule. Key context: Site-neutral payments — when Medicare pays the same amount for the same service regardless of where it's provided — have gotten bipartisan support on Capitol Hill. But packages have never made it across the finish line partly due to fervent lobbying from the hospital industry, which argues the payment cuts would imperil the finances of vulnerable hospitals. What's next: The rule has a 60-day comment period before final approval. WHAT WE'RE READING POLITICO's Lauren Gardner reports on Democratic Sen. Richard Blumenthal suggesting he's open to changing the federal vaccine injury program. KFF Health News' Darius Tahir reports in NPR that researchers fear a program that collects DNA data from millions of retired military service members could be in limbo. Endpoints News' Jared Whitlock reports on the Trump administration's disbanding of a newborn screening panel for rare conditions.
